| Jolene Jewell, MD | |
|
3008 Pickett Rd, Durham, NC 27705-6006 | |
| (919) 286-7903 | |
| (919) 286-7151 |
| Full Name | Jolene Jewell |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 12 Years |
| Location | 3008 Pickett Rd, Durham, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518227081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 201601401 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greensboro Dermatology Assoc Pa | 2860405115 | 7 |
News Archive
Blocking the fat-busting enzyme lipoxygenase with a synthetic inhibitor throws the immune system's innate inflammatory response out of whack, compromising cardiac repair during acute heart failure, USF Health researchers found.
New research has found no increased risk of congenital malformations associated with treatment with radiotherapy or chemotherapy in children of fathers with testicular cancer.
Patients with a serious type of inflammatory bowel disease, ulcerative colitis, are not satisfied with their current treatments and the majority do not have their disease under control, according to new research released today at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen. The majority (87.2 per cent) of the 250 patients with moderate to severe ulcerative colitis who were being treated with standard therapies failed to achieve control of their disease – defined either as going into remission or not having needed to use corticosteroid medications in the previous two months.1
Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program, a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.
› Verified 9 days ago
| Entity Name | Greensboro Dermatology Assoc Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043272784 PECOS PAC ID: 2860405115 Enrollment ID: O20060818000339 |
News Archive
Blocking the fat-busting enzyme lipoxygenase with a synthetic inhibitor throws the immune system's innate inflammatory response out of whack, compromising cardiac repair during acute heart failure, USF Health researchers found.
New research has found no increased risk of congenital malformations associated with treatment with radiotherapy or chemotherapy in children of fathers with testicular cancer.
Patients with a serious type of inflammatory bowel disease, ulcerative colitis, are not satisfied with their current treatments and the majority do not have their disease under control, according to new research released today at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen. The majority (87.2 per cent) of the 250 patients with moderate to severe ulcerative colitis who were being treated with standard therapies failed to achieve control of their disease – defined either as going into remission or not having needed to use corticosteroid medications in the previous two months.1
Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program, a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jolene Jewell, MD 3008 Pickett Rd, Durham, NC 27705-6006 Ph: (919) 286-7903 | Jolene Jewell, MD 3008 Pickett Rd, Durham, NC 27705-6006 Ph: (919) 286-7903 |
News Archive
Blocking the fat-busting enzyme lipoxygenase with a synthetic inhibitor throws the immune system's innate inflammatory response out of whack, compromising cardiac repair during acute heart failure, USF Health researchers found.
New research has found no increased risk of congenital malformations associated with treatment with radiotherapy or chemotherapy in children of fathers with testicular cancer.
Patients with a serious type of inflammatory bowel disease, ulcerative colitis, are not satisfied with their current treatments and the majority do not have their disease under control, according to new research released today at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen. The majority (87.2 per cent) of the 250 patients with moderate to severe ulcerative colitis who were being treated with standard therapies failed to achieve control of their disease – defined either as going into remission or not having needed to use corticosteroid medications in the previous two months.1
Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program, a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.
› Verified 9 days ago
John F Carr, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4012 Colville Rd, Durham, NC 27707 Phone: 919-489-1826 | |
Dr. John Carroll Murray, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: Box 2907 Div Derm Duke Univ Med Center, Durham, NC 27710 Phone: 919-684-2393 Fax: 919-684-6505 | |
Brooke A Jackson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 245 E Nc Highway 54, Suite 202, Durham, NC 27713 Phone: 919-294-9440 Fax: 919-237-3899 | |
Dr. Michelle Bernadette Pavlis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5324 Mcfarland Rd, Suite 210, Durham, NC 27707 Phone: 919-684-8111 | |
Dr. Sabrina Michelle Shearer, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5324 Mcfarland Rd, Durham, NC 27707 Phone: 919-401-3376 Fax: 919-401-0378 | |
Dr. Lawrence Etter, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3008 Pickett Rd, Durham, NC 27705 Phone: 919-286-7903 Fax: 919-286-7151 | |
Elizabeth L. West, P.A. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2100 Erwin Rd, Durham, NC 27710 Phone: 919-684-8111 |